Man Group
PCVX icon

Man Group’s Vaxcyte PCVX Stock Holding History

Man Group’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.12M Sell
19,257
-49,656
-72% -$2.7M ﹤0.01% 1795
2025
Q4 		$3.18M Sell
68,913
-175,984
-72% -$7.87M 0.01% 1266
2025
Q3 		$8.82M Buy
244,897
+215,402
+730% +$7.14M 0.02% 853
2025
Q2 		$959K Sell
29,495
-739
-2% -$24.2K ﹤0.01% 1642
2025
Q1 		$1.14M Sell
30,234
-112,192
-79% -$8.97M ﹤0.01% 1554
2024
Q4 		$11.7M Buy
142,426
+127,875
+879% +$12.7M 0.04% 669
2024
Q3 		$1.66M Buy
+14,551
New +$1.31M ﹤0.01% 1369
2023
Q2 		– Hold
0
– -$955K – 2155
2023
Q1 		– Hold
0
– – – 1349

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return